Physician

Alberto B. Vasquez, M.D.

According to 2025 Medicare claims, Alberto Vasquez, M.D. (NPI: 1881680114) practices neurology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is CENTRAL NEUROLOGY, P.L. (NPI: 1477854768; TIN: 320223568) and primary practice location at 33713-8844.

Vasquez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 548 traditional Medicare patients, billed 33,213 HCPCS/CPT codes, and received $747,206 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,690 prescription claims across 607 beneficiaries totaling $3,293,078 in drug costs, led by Privigen (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 32 claims. Open Payments data shows 152 records totaling $34,933. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $239,347 to $747,206. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,238 and ending at $4,740.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	534	13,123	$239,347
2016	527	14,632	$254,262
2017	670	17,976	$315,580
2018	656	21,278	$334,034
2019	682	26,418	$437,712
2020	586	26,509	$612,818
2021	631	29,060	$707,856
2022	645	32,983	$753,943
2023	560	29,258	$691,261
2024	548	33,213	$747,206

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	327	3,120	$2,856,787
2016	357	3,214	$3,143,732
2017	410	3,527	$4,185,842
2018	404	3,613	$4,694,440
2019	424	3,644	$4,616,937
2020	441	3,558	$4,980,593
2021	503	3,845	$4,247,677
2022	537	3,739	$3,623,423
2023	590	3,641	$3,043,439
2024	607	3,690	$3,293,078

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	103	$2,689
2016	11	202	$5,547
2017	68	179	$3,603
2018	52	157	$3,452
2019	11	130	$5,188
2020	41	306	$12,454
2021	40	205	$8,084
2022	17	144	$8,229
2023	N/R	98	$3,853
2024	N/R	32	$2,280

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	138	138	$160
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	128	142	$134
95910	Nerve conduction, 7-8 studies	83	84	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	276	399	$90
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	184	334	$71

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	35	787	$743,651
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	45	1,267	$687,529
Tecfidera	Dimethyl Fumarate	19	570	$178,325
Vumerity	Diroximel Fumarate	15	450	$132,086
Aubagio	Teriflunomide	13	390	$118,687

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	32	$2,280

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$3,615	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$31,318	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alberto B. Vasquez, M.D.?

Tedicare shows public-source Medicare data for Alberto B. Vasquez, M.D. (NPI 1881680114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto B. Vasquez, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alberto B. Vasquez, M.D.?

Alberto B. Vasquez, M.D. is linked to CENTRAL NEUROLOGY, P.L. (billing NPI 1477854768) in the available physician profile data.

Does Alberto B. Vasquez, M.D. have Open Payments data?

Alberto B. Vasquez, M.D. has 152 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.